Psc-Dependent Stem Cell Engineering for Management of Cancer and Its Current Challenges

Rhitoban Ghosh; Madhu Parna Karmakar; Mohima Mitra; Susanta Roy Karmakar; Sujit Kumar Bhowal

doi:10.36948/ijfmr.2024.v06i06.31272

Psc-Dependent Stem Cell Engineering for Management of Cancer and Its Current Challenges

Author(s)	Rhitoban Ghosh, Madhu Parna Karmakar, Mohima Mitra, Susanta Roy Karmakar, Sujit Kumar Bhowal
Country	India
Abstract	Stem cells are not only used for regenerative medicine, but also considered as a useful tool for cancer therapy. Pluripotent stem cells are promising tools in these kinds of therapies because of their stemness properties (that includes unlimited self-renewal & ability to differentiate into all cell types in the body). After discovery, the potentials of induced Pluripotent stem cells (iPSCs) have been explored by several researchers to unravel the molecular mechanism responsible for cancer initiation and progression. A rare population of cells within tumor, known as Cancer stem cells (CSCs), exhibit stemness & phenotypic plasticity that are mainly responsible for resistance to chemotherapy, metastasis, radiotherapy, cancer development & tumor relapse. Off late, stem cells are being engineered to carry therapeutic reagents to target the tumor sites. Cancer vaccines based on knowledge of CSCs have been studied and applied for cancer treatment. Further applications of this technology include high-throughput drug screening, epigenetic reprogramming of cancer cells to normal, immunotherapy & regenerative cell therapies. iPSCs have been used to create active T cells to support cancer immunotherapy. The similarities between CSCs and Pluripotent stem cells (PSCs) can provide an appropriate source of CSC specific antigens by cultivation of PSCs which could help in the development of prophylactic & therapeutic cancer vaccine. This review discusses induced pluripotent stem cells, stem cell applications in transplantation, cancer stem cells, comparison between PSCs to CSCs, potential of stem cells engineering to revolutionize cancer treatment and current challenges on clinical applications.
Keywords	Stem cells, Cancer, Embryonic stem cells, Cancer stem cells, Stem cell therapy, Cancer vaccine, Pluripotency
Field	Biology > Zoology
Published In	Volume 6, Issue 6, November-December 2024
Published On	2024-11-27
Cite This	Psc-Dependent Stem Cell Engineering for Management of Cancer and Its Current Challenges - Rhitoban Ghosh, Madhu Parna Karmakar, Mohima Mitra, Susanta Roy Karmakar, Sujit Kumar Bhowal - IJFMR Volume 6, Issue 6, November-December 2024. DOI 10.36948/ijfmr.2024.v06i06.31272
DOI	https://doi.org/10.36948/ijfmr.2024.v06i06.31272
Short DOI	https://doi.org/g8sdgb

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6 Cover Page Vol 6 Isu 5 Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Psc-Dependent Stem Cell Engineering for Management of Cancer and Its Current Challenges

Share this